| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.765 | 28.173 | 0 | 0 | 860 | 645 | 625 | 608 | 6.917 | 6.513 |
| Total Income - EUR | 16.765 | 28.173 | 0 | 0 | 860 | 645 | 625 | 608 | 6.917 | 6.513 |
| Total Expenses - EUR | 1.323 | 5.161 | 701 | 248 | 330 | 378 | 320 | 261 | 1.816 | 3.414 |
| Gross Profit/Loss - EUR | 15.442 | 23.013 | -701 | -248 | 530 | 266 | 305 | 348 | 5.101 | 3.099 |
| Net Profit/Loss - EUR | 14.939 | 22.329 | -701 | -248 | 504 | 247 | 288 | 332 | 4.259 | 2.608 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Beta Cardiovascular Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 15.457 | 23.407 | 0 | 0 | 345 | 707 | 801 | 1.165 | 5.419 | 5.844 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 8.477 | 7.299 | 0 | 0 | 0 | 0 | 2 | 608 | 2 | 1.102 |
| Cash | 6.980 | 16.108 | 0 | 0 | 345 | 707 | 798 | 556 | 5.417 | 4.741 |
| Shareholders Funds | 14.742 | 22.383 | 0 | -248 | 261 | 503 | 781 | 1.115 | 4.307 | 2.656 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 716 | 1.025 | 0 | 248 | 84 | 204 | 20 | 50 | 1.112 | 3.188 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Beta Cardiovascular Srl